Skip to main content
Fig. 4 | BMC Musculoskeletal Disorders

Fig. 4

From: Are paraspinous intramuscular injections of botulinum toxin a (BoNT-A) efficient in the treatment of chronic low-back pain? A randomised, double-blinded crossover trial

Fig. 4

Estimated impact of low-back pain on quality of life at D0, D30, D90 and D120 for patients treated by Botulinum toxin A (group A) or by placebo (group B). It was measured on a horizontal visual analogue scale 100 mm long. The question asked was: "in your opinion, how was your quality of life over the last month?" (0 = no impact to 100 = major deterioration)

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us